List of large molecules
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| US6407213 | GENENTECH, INC. | Method for making humanized antibodies |
Jun, 2020
(3 years ago) | |
| US6716602 | GENENTECH, INC. | Metabolic rate shifts in fermentations expressing recombinant proteins |
Nov, 2021
(1 year, 10 months ago) | |
| US6828121 | GENENTECH, INC. | Bacterial host strains |
Jul, 2022
(1 year, 2 months ago) | |
| US9688775 | GENENTECH, INC. | System for antibody expression and assembly |
Dec, 2022
(8 months ago) | |
| US6921659 | GENENTECH, INC. | Protease-deficient cells |
Oct, 2023
(16 days from now) | |
| US8383773 | GENENTECH, INC. | Protein product and method for reducing biomass-biomass interactions |
Dec, 2023
(2 months from now) | |
| US8574869 | GENENTECH, INC. | Prevention of disulfide bond reduction during recombinant production of polypeptides |
Jul, 2028
(4 years from now) | |
| US10421984 | GENENTECH, INC. | Methods for reducing norleucine misincorporation into proteins using a microorganism comprising a mutant metA allele |
Sep, 2033
(9 years from now) | |
| US9765379 | GENENTECH, INC. | Harvest operations for recombinant proteins |
Mar, 2034
(10 years from now) | |
| US10017732 | GENENTECH, INC. | Cell culture compositions with antioxidants and methods for polypeptide production |
Mar, 2034
(10 years from now) | |
| US10829732 | GENENTECH, INC. | Cell culture compositions with antioxidants and methods for polypeptide production |
Mar, 2034
(10 years from now) | |
| US10112994 | GENENTECH, INC. | Methods of producing two chain proteins in bacteria |
Nov, 2035
(12 years from now) |
Ingredients: RANIBIZUMAB
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic